Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol. (Q35555966)
Jump to navigation
Jump to search
scientific article published on 11 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol. |
scientific article published on 11 February 2005 |
Statements
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol (English)
F Atzeni
F Buttgereit
M Carrabba
11 February 2005